PM2.5染毒HBE细胞前后差异表达的microRNAs及其生物信息学分析

doi:10.3969/j.issn.1004-616x.2020.05.005

摘要/Abstract

摘要： 目的：采用microRNA（miRNA）测序和生物信息学方法，分析大气细颗粒物（PM_2.5）染毒人支气管上皮HBE细胞前后差异表达的miRNAs，预测差异miRNAs的生物学功能和信号转导途径。方法：用50 μg/mL的PM_2.5混悬液染毒HBE细胞，以未染毒组作为对照组，处理24 h后提取总RNA样品，Small RNA样品预处理试剂盒构建文库，并利用illumina HiSeq^TM 2500/MiSeq测序平台进行高通量测序。以调整后P < 0.05的筛选标准得到差异miRNAs，使用miRanda和RNAhybrid两个软件共同预测差异miRNAs的靶基因并进行GO和KEGG功能富集分析，利用STRING数据库和Cytoscape软件对miRNAs和靶基因及靶基因之间的相互作用关系进行可视化分析。结果：高通量测序方法共检测到PM_2.5染毒前后的包含1 137个miRNAs的表达谱，27个为差异表达的miRNAs，其中7个上调，20个下调。GO和KEGG富集分析发现，这些差异miRNAs主要参与细胞代谢、酶活性调节等生物学过程，聚集于胞内如细胞质、细胞器等，涉及代谢途径、PI3K-Akt信号通路、Ras信号通路、MAPK信号通路等与细胞增殖、分化、凋亡及癌症发生等相关的重要信号通路。此外，通过构建相互作用网络图，鉴定了miR-371b-3p、miR-371a-5p、miR-27a-3p、miR-7-5p、miR-372-3p等相互作用数量前11位的核心miRNAs，以及3个核心靶基因（VEGFA、MAPK3、CCR5）。结论：PM_2.5染毒HBE细胞后引起了27个miRNAs的差异表达，涉及PI3K-Akt信号通路、Ras信号通路及MAPK信号通路等与癌症发生发展相关的重要信号通路，其中筛选了11个核心miRNAs和3个核心基因，为深入研究PM_2.5致癌毒理作用机制提供了实验依据。

关键词: 大气细颗粒物, 人支气管上皮细胞, microRNA, 生物信息学, 信号通路

Abstract: OBJECTIVE: To investigate effects of PM_2.5 on HBE cells using microRNA (miRNA) sequencing and bioinformatics methods. METHODS: HBE cells were treated with 50 μg/mL PM_2.5 suspension and untreated cells were used as control. Total RNA samples were extracted 24 hours later. The Small RNA sample pretreatment kit was used to construct a library and the illumina HiSeq^TM 2500/MiSeq sequencing platform was used for high-throughput sequencing. The differentially expressed miRNAs were obtained according to the screening criteria of adjusted P < 0.05,and the target genes of the differentially expressed miRNAs were predicted by miRanda and RNAhybrid software,and then GO and KEGG function enrichment analyses were performed. The STRING database and the Cytoscape software were used to visualize interactions between miRNAs and target genes and between target genes. RESULTS: Using high-throughput sequencing methods,a total of 1 137 miRNAs were detected before and after PM_2.5 exposure in HBE cells. Among them,27 miRNAs were differentially expressed,including 7 up-regulated and 20 down-regulated. The enrichment analyses using GO and KEGG show that these differential miRNAs were mainly involved in biological processes such as cell metabolism and enzyme activity regulation. They are mainly involved with metabolic,PI3K-Akt signaling,cancer,Ras signaling,MAPK signaling pathways,etc. related to cell proliferation,differentiation,apoptosis and cancer. By constructing an interaction network diagram,the core miRNAs with the number of TOP 11 interactions such as miR-371b-3p,miR-371a-5p,miR-27a-3p,miR-7-5p,miR-372-3p,and 3 core target genes (VEGFA,MAPK3,CCR5) were identified. CONCLUSION: 27 miRNAs were differentially expressed after HBE cells were exposed to PM_2.5. These miRNAs are involved with the PI3K-Akt signaling,Ras signaling,MAPK signaling pathways,etc. which are involved with the development of cancer. Among them,11 core miRNAs and 3 core genes were screened,our results provide the scientific basis for further study of the carcinogenic mechanism of PM_2.5.

Key words: PM_2.5, human bronchial epithelial cells, microRNA, bioinformatics, signal pathway

中图分类号:

R122.7

蔡颖, 李闰冰, 郑凯, 秦双建, 李柏茹, 张朝晖, 徐新云. PM_2.5染毒HBE细胞前后差异表达的microRNAs及其生物信息学分析[J]. 癌变·畸变·突变, 2020, 32(5): 355-362.

CAI Ying, LI Runbing, ZHENG Kai, QIN Shuangjian, LI Boru, ZHANG Zhaohui, XU Xinyun. Differential microRNAs expression and bioinformatics analyses in HBE cells exposed to PM_2.5[J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(5): 355-362.

参考文献

[1] LI R, ZHOU R, ZHANG J. Function of PM_2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases[J]. Oncol Lett, 2018, 15(5):7506-7514.
[2] FAN J, LI S, FAN C, et al. The impact of PM_2.5 on asthma emergency department visits:a systematic review and meta-analysis[J]. Environ Sci Pollut Res Int, 2016, 23(1):843-850.
[3] MIRABELLI M C, VAIDYANATHAN A, FLANDERS W D, et al. Outdoor PM_2.5, ambient air temperature, and asthma symptoms in the past 14 days among adults with active asthma[J]. Environ Health Perspect, 2016, 124(12):1882-1890.
[4] 王冰玉, 蔡颖, 郑凯, 等. PM_2.5对HBE细胞致癌致突变相关基因表达的影响[J]. 癌变·畸变·突变, 2020, 32(1):33-38, 42.
[5] 王冰玉, 郑凯, 徐新云, 等. PM_2.5对支气管上皮细胞DNA损伤作用研究[J]. 癌变·畸变·突变, 2019, 31(6):469-473, 497.
[6] 郑凯, 王冰玉, 徐新云, 等. 深圳和太原PM_2.5样品致突变作用研究[J]. 癌变·畸变·突变, 2019, 31(6):483-487.
[7] LI P, WANG J P, GUO F J, et al. A novel inhibitory role of microRNA-224 in particulate matter 2.5-induced asthmatic mice by inhibiting TLR2[J]. J Cell Mol Med, 2020, 24(5):3040-3052.
[8] LIU C, GUO H, CHENG X, et al. Exposure to airborne PM_2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells[J]. Oncotarget, 2015, 6(30):29428-29439.
[9] BRONEVETSKY Y, MARK ANSEL K. Regulation of miRNA biogenesis and turnover in the immune system[J]. Immunol Rev, 2013, 253(1):304-316.
[10] YANG D, MA M Y, ZHOU W Q, et al. Inhibition of miR-32 activity promoted EMT induced by PM_2.5 exposure through the modulation of the Smad1-mediated signaling pathways in lung cancer cells[J]. Chemosphere, 2017, 184:289-298.
[11] 黄怡颖, 张健. miRNA-17-5p、miRNA-103-3p及miRNA-144-3p在急性缺血性脑卒中中的表达及诊断价值研究[J]. 国际检验医学杂志, 2020, 41(9):1105-1108.
[12] RUPAIMOOLE R, SLACK F J. microRNA therapeutics:towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov, 2017, 16(3):203-222.
[13] 孙云菊, 张星, 陆幼波, 等. miRNA-380-5p在乳腺癌细胞增殖和凋亡中的作用机制[J]. 中国妇幼保健, 2020, 35(11):2097-2100.
[14] ALI SYEDA Z, LANGDEN S S S, MUNKHZUL C, et al. Regulatory mechanism of microRNA expression in cancer[J]. Int J Mol Sci, 2020, 21(5):1723.
[15] 周学, 杜宜兰, 金萍, 等. 癌症相关microRNA与靶基因的生物信息学分析[J]. 遗传, 2015, 37(9):855-864.
[16] 侯天芳, 廖纪萍, 马元元, 等. 大气细颗粒物暴露后小鼠肺组织microRNA差异表达谱芯片分析[J]. 生态毒理学报, 2018, 13(1):138-146.
[17] MA H P, KONG W X, LI X Y, et al. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR[J]. Oncol Rep, 2019, 41(3):1549-1559.
[18] WANG Z, LI J J, LONG X B, et al. MRPS16 facilitates tumor progression via the PI3K/AKT/Snail signaling axis[J]. J Cancer, 2020, 11(8):2032-2043.
[19] PRADHAN R, SINGHVI G, DUBEY S K, et al. MAPK pathway:a potential target for the treatment of non-small-cell lung carcinoma[J]. Futur Med Chem, 2019, 11(8):793-795.
[20] SOLEIMANI A, RAHMANI F, SAEEDI N, et al. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer[J]. J Cell Biochem, 2019, 120(12):19245-19253.
[21] YUE L, GUO J. lncRNA TUSC7 suppresses pancreatic carcinoma progression by modulating miR-371a-5p expression[J]. J Cell Physiol, 2019, 234(9):15911-15921.
[22] ZHU L, WANG Z, FAN Q, et al. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS[J]. Oncol Rep, 2014, 31(1):280-286.
[23] LI K, ZHU X R, CHEN X H, et al. microRNA-27a-3p promotes epithelial-mesenchymal transition by targeting NOVA alternative splicing regulator 1 in gastric cancer[J]. Mol Med Report, 2020:21(3):1615-1622.
[24] LU Q, SHAN S, LI Y, et al. Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p[J]. Faseb J, 2018, 32(7):3957-3967.
[25] ZHANG Y, TA W, SUN P, et al. Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma[J]. Int J Clin Exp Pathol, 2019, 12(7):2536.
[26] DONG M J, XIE Y Y, XU Y D. miR-7-5p regulates the proliferation and migration of colorectal cancer cells by negatively regulating the expression of Krüppel-like factor 4[J]. Oncol Lett, 2019, 17(3):3241-3246.
[27] WANG Q, LIU S Y, ZHAO X T, et al. MiR-372-3p promotes cell growth and metastasis by targeting FGF₉ in lung squamous cell carcinoma[J]. Cancer Med, 2017, 6(6):1323-1330.
[28] YANG Z Q, WU C G, CHENG Y X. Prognostic value of microRNA-133a expression and its clinicopathologic significance in non-small cell lung cancer:a comprehensive study based on meta-analysis and the TCGA database[J]. Onkologie, 2018, 41(12):762-768.
[29] 薛无涯, 王舰梅, 夏天, 等. miR-204-5p对结直肠癌细胞增殖、侵袭、迁移及上皮间质转化的影响[J]. 西南医科大学学报, 2018, 41(2):104-110.
[30] CHEN X, XU X, PAN B, et al. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer[J]. Aging (Albany NY), 2018, 10(11):3421-3437.
[31] CAO H Y, XIAO C H, LU H J, et al. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3[J]. Eur Rev Med Pharmacol Sci, 2019, 23(15):6478-6485.
[32] PERVAIZ A, ZEPP M, MAHMOOD S, et al. CCR5 blockage by maraviroc:a potential therapeutic option for metastatic breast cancer[J]. Cell Oncol (Dordr), 2019, 42(1):93-106.